HealthReady, a firm combining blockchain technology and medical information, has made a major breakthrough by launching on the Hedera main network This ground-breaking innovation represents the fusion of cutting-edge blockchain capabilities with priceless healthcare data, which is reportedly fifty times more significant than financial records.
The ultimate objective of HealthReady information is kept to make sure that healthcare to the highest standards, remains in the hands of the patients, safely and securely. can be distributed for research purposes Hedera Consensus Service (HCS) is a tool that HealthReady uses to authenticate patient-provided outcome data and confirm patient consent for access to their healthcare data in order to achieve this goal.
In addition to the Health Care System, HealthReady uses Hedera Token Service to create its own token named $HBAR. This provides an incentive for patient involvement and allows those suffering from rare diseases or conditions to have more control over their health data. They can manage it and decide who they wish to share the information with, which gives them a chance of being a part of potentially life-saving clinical research projects.
HealthReady seeks to achieve two key goals, both of which are beneficial to healthcare. Firstly, granting users control over their data and allowing them to participate in clinical trials gives a more diverse range of patient information for analysis. Secondly, this increases the overall quality of the data used which leads to more accurate research results.
Coinbase, a well-known cryptocurrency trading platform, has given its stamp of approval to HealthReady’s blockchain solution. Coinbase believes that this technology can have an impact on the world and has highlighted it as a representation of how powerful blockchain can be.
One of the most difficult tasks in healthcare is obtaining participants for clinical trials. It takes a significant amount of money and time to find an appropriate group, particularly when it’s a diverse population. This situation becomes especially difficult with rare diseases affecting children because the availability of suitable candidates is even more limited.
HealthReady is tackling the issue of clinical research recruitment with a comprehensive solution. They provide a pool of confirmed, qualified patients that have access to high-quality health data. This makes the process of designing and recruiting for studies more effective and efficient, resulting in improved outcomes overall.
HealthReady has taken on the challenge of helping parents and children with Neuroblastoma, an uncommon cancer that mainly impacts youngsters. With their system, HealthReady provides these families with the means to use their medical records as a tool for finding and being chosen for clinical research studies. This could potentially bring about new treatments or enhance the quality of life for vulnerable kids afflicted by this disease.
Importantly, HealthReady prioritizes the needs of its patients in decision-making. A truly patient-centric approach gives patients the autonomy to access and input their health data, agree to having their identities used in research, and choose whether or not to take part in clinical studies.
Maria Palombini, an authority on healthcare data security, saw a great opportunity in joining the two fields of healthcare and blockchain. She pointed out how this technology can improve information accuracy, privacy safeguards and most importantly, lead to better results for patients.
HealthReady was committed to finding a solution that would enable them to offer token incentives, preserve data accuracy and provide timely reporting. To achieve this goal, they sought out DLT technology which is well-known for its scalability and dependability. This way, they could extend their services to more people who are not traditionally served as well as create novel treatments for illness and diseases.
Hedera has become the preferred platform for global companies wanting to use their abilities in a healthcare setting. With its capacity to reach consensus and remarkable capacity for scaling, Hedera is an ideal fit with HealthReady’s mission of enhancing access to research information for patients and improving data quality for researchers.
Jim Nasr, the CEO of Acoer and a leader at The HBAR Foundation Privacy and Healthcare Fund, strongly believes that data on patient health must be accurate, reliable and authenticated for diseases like Neuroblastoma. Together with Hedera’s help, HealthReady is making progress toward revolutionizing medical services by providing patients with greater access to research projects and more precise data for investigators to utilize.
HealthReady’s conjunction to the Hedera mainnet is a tremendous stride forward in modifying medical data, which could be greatly beneficial for research and patient welfare. This combination has the capacity to cause massive renovations in clinical investigations and patient outcomes.